Histological and Clinical Findings in Rabbits Sensitized with GM1 Ganglioside
DOI:
https://doi.org/10.3889/oamjms.2020.4871Keywords:
Acute motor axonal neuropathy, Animal model, GM1 gangliosideAbstract
BACKGROUND: Acute motor axonal neuropathy (AMAN) is a peripheral nerve disorder that attacks motor axons and occurs acutely. AMAN is one type of Guillain–Barre syndrome (GBS) which often attacks men of productive age. Until now, although patients have undergone intravenous immunoglobulin (IVIG) therapy and/or plasmapheresis, long-standing disability remains a problem. In Indonesia, the availability and cost of these therapies are constraints.
AIM: Our study aimed to find a proper animal model suitable for AMAN and can be executed in our institution, Naval Health Institute with a hope to find new therapeutic modalities in healing with AMAN.
METHODS: GM1 ganglioside immunized in New Zealand male white rabbits with complete Freund’s adjuvant, every 3 weeks until 20 weeks. We evaluated the effects GM1 ganglioside on body weight, functional score, and axon degeneration’s scale. Functional score was examined based on Tarlov’s. Hematoxylin-eosin was used to stain this slide.
RESULTS: Rabbits that being immunized with GM1 ganglioside experience a number of neurological signs and symptoms that resemble AMAN, that is, sluggish righting reflex, muscular weakness, flaccid hyper paralysis, and body weight loss. Pathological examination shows extensive degeneration of peripheral nerves, infiltration of macrophages, and perineuritis.
CONCLUSION: This histological and clinical findings support that this neuropathy is induced by an autoimmune response delivered by cells that respond to gangliosides.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Tandel H, Pandya N, Pharmaceuticals A, Jani P. Guillain-barré syndrome (GBS): A review. Curr Med Res Opin. 2016;3(2):366-71.
Seneviratne U. Guillain-Barre syndrome. Postgrad Med J. 2000;76(902):774-82. https://doi.org/10.1136/pgmj.76.902.774 PMid:11085768
Walling AD, Dickson G. Guillain-Barré Syndrome. 2013. p. 191-8.
Willison HJ. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002;125(12):2591-625. https://doi.org/10.1093/brain/awf272 PMid:12429589
Burns TM. Guillain-Barré syndrome. Semin Neurol. 2008;28(2):152-67. PMid:18351518
Thomas FP, Trojaborg W, Nagy C, Santoro M, Sadiq SA, Latov N, et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol. 1991;82(5):378-83. https://doi.org/10.1007/bf00296548 PMid:1767631
Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol. 2001;49(6):712-20. https://doi.org/10.1002/ana.1012 PMid:11409422
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717-27. https://doi.org/10.1016/s0140-6736(16)00339-1 PMid:26948435
van Buskirk C. Clinical neurology. J Nerv Ment Dis. 1964;139(6):598.
Nagai Y, Momoi T, Saito M, Mitsuzawa E, Ohtani S. Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett. 1976;2(2):107-11. https://doi.org/10.1016/0304-3940(76)90033-1
Carriel V, Garzón I, Alaminos M, Campos A. Evaluation of myelin sheath and collagen reorganization pattern in a model of peripheral nerve regeneration using an integrated histochemical approach. Histochem Cell Biol. 2011;136(6):709-17. https://doi.org/10.1007/s00418-011-0874-3 PMid:22038043
Abu Rafee M, Sharma GT. Short communication comparison of hematoxylin and eosin staining with and without pre treatment with marchi’s solution on nerve samples for nerve degeneration and regeneration studies. Explor Anim Med Res. 2017;7(2):206.
Lichtman H, Lichtman H, Abbas A. Cellular and Molecular Immunology. Amsterdam, Netherlands: Elsevier; 2005.
Dalakas MC. Pathogenesis of immune-mediated neuropathies. Biochim Biophys Acta 2015;1852(4):658-66. PMid:24949885
Bourque PR, Chardon JW, Massie R. Autoimmune peripheral neuropathies. Clin Chim Acta. 2015;449:37-42. https://doi.org/10.1016/j.cca.2015.02.039
Downloads
Published
How to Cite
License
Copyright (c) 2020 Ni Komang Sri Dewi Untari, Kurnia Kusumastuti , Guritno Suryokusumo, I Ketut Sudiana, Tedy Juliandhy (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0